HUTCHMED (CHINA) LIMITED - AMERICAN DEPOSITARY SHA
19.90
21-五月-24 15:59:51
15 分钟延时
股票
-0.19
-0.95%
今日范围
19.68 - 20.09
ISIN
N/A
来源
NASDAQ
-
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
17 4月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Highlights Presentations at American Association for Cancer Research Annual Meeting 2023
11 4月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
Intended Retirement of Independent Non-executive Director
11 4月 2023 04:30:00 条件 Nasdaq GlobeNewswire
-
04 4月 2023 05:30:00 条件 Nasdaq GlobeNewswire
-
30 3月 2023 20:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces Closing of Fruquintinib License to Takeda Outside China
14 3月 2023 09:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Confirms No Assets Held at Silicon Valley Bank
12 3月 2023 20:07:31 条件 Nasdaq GlobeNewswire
-
HUTCHMED Reports 2022 Full Year Results and Provides Business Updates
28 2月 2023 03:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED to Announce 2022 Final Results
31 1月 2023 03:30:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
23 1月 2023 03:00:55 条件 Nasdaq GlobeNewswire
-
18 1月 2023 09:30:00 条件 Nasdaq GlobeNewswire
-
03 1月 2023 03:30:00 条件 Nasdaq GlobeNewswire
-
19 12月 2022 05:00:00 条件 Nasdaq GlobeNewswire
-
HUTCHMED Announces Strategy to Focus on Late-Stage Pipeline Regulatory Approvals
14 11月 2022 19:00:00 条件 Nasdaq GlobeNewswire
-
13 11月 2022 19:00:00 条件 Nasdaq GlobeNewswire
-
27 10月 2022 07:30:00 条件 Nasdaq GlobeNewswire
-
10 10月 2022 04:30:00 条件 Nasdaq GlobeNewswire
-
07 9月 2022 18:30:00 条件 Nasdaq GlobeNewswire
-
23 8月 2022 04:30:00 条件 Nasdaq GlobeNewswire
-
Inmagene and HUTCHMED Announce First Participant in Global Phase I Trial of IMG-004
09 8月 2022 04:30:00 条件 Nasdaq GlobeNewswire